ScholarIQanswers from OpenAlex & ORCID
Christos S. Mantzoros
ResearcherPublications, citations & collaboration network
Christos S. Mantzoros is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Christos S. Mantzoros have?
ScholarIQindexed works
Christos S. Mantzoros has 942 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Christos S. Mantzoros have?
ScholarIQcitation count
Christos S. Mantzoros has 80,436 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Christos S. Mantzoros?
ScholarIQh-index
Christos S. Mantzoros has an h-index of 144 in OpenAlex.
What is the i10-index of Christos S. Mantzoros?
ScholarIQi10-index
Christos S. Mantzoros has an i10-index of 645 in OpenAlex.
What is the ORCID of Christos S. Mantzoros?
ScholarIQorcid
The ORCID for Christos S. Mantzoros is on the source record.
What is the OpenAlex record for Christos S. Mantzoros?
ScholarIQopenalex
The OpenAlex for Christos S. Mantzoros is on the source record.
What are the most-cited papers on Christos S. Mantzoros?
ScholarIQmost cited works
Physiology and role of irisin in glucose homeostasis
Nikolaos Perakakis, G. Triantafyllou, José Manuel Fernández‐Real, Joo Young Huh, Kyung‐Hee Park, Jochen Seufert, Christos S. Mantzoros
Adiponectin and Breast Cancer Risk
Christos S. Mantzoros, Eleni Petridou, Nick Dessypris, Charilaos Chavelas, Μaria Dalamaga, Delia Marina Alexe, Yannis Papadiamantis, Christos Markopoulos, Evangelos Spanos, George P. Chrousos, Dimitrios Trichopoulos
Cohort Profile: Project Viva
Emily Oken, Andrea Baccarelli, Diane R. Gold, Ken Kleinman, Augusto A. Litonjua, Dawn De Meo, Janet W. Rich‐Edwards, Sheryl L. Rifas‐Shiman, Sharon K. Sagiv, Elsie M. Taveras, Scott T. Weiss, Mandy B. Belfort, Heather H. Burris, Carlos A. Camargo, Susanna Y. Huh, Christos S. Mantzoros, Margaret G. Parker, Matthew W. Gillman
Circulating Adiponectin and Endometrial Cancer Risk
Luigino Dal Maso, Livia S. A. Augustin, Aspasia Karalis, Renato Talamini, Silvia Franceschi, Dimitrios Trichopoulos, Christos S. Mantzoros, Carlo La Vecchia
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
Vasilios G. Athyros, Theodore K. Alexandrides, Helen Bilianou, Εvangelos Cholongitas, Michael Doumas, Emmanuel S. Ganotakis, John Goudevenos, Moses Elisaf, Georgios Germanidis, Όλγα Γιουλεμέ, Asterios Karagiannis, Charalambos Karvounis, Niki Katsiki, Vasilios Kotsis, Jannis Kountouras, Evangelos Liberopoulos, Christos Pitsavos, Stergios Polyzos, Lοukianos S. Rallidis, Dimitrios Richter, Απόστολος Τσάπας, Alexandros D. Tselepis, Konstantinos Tsioufis, Κωνσταντίνος Τζιόμαλος, Themistoklis Tzotzas, Themistoklis G. Vasiliadis, Charalambos Vlachopoulos, Dimitri P. Mikhailidis, Christos S. Mantzoros